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1. Introduction 
Normal mammalian tissues contain two forms of 
cu-L-fucosidase, distinguishable by their gel-filtration 
behaviour as a macromolecular fucosidase I and a low 
mol. wt fucosidase II [ 1,2] . They can be also 
distinguished by their pH-activity profiles and by 
differing responses to heat denaturation. The recent 
introduction of the fluorigenic substrate 4-methylum- 
belliferyl a-Lfucoside allows a more detailed study by 
electrophoretic methods and it is clear that within 
these two main forms there is some further heterogen- 
eity. Gel electrophoresis of a-fucosidases from serum 
and from cultured cells have revealed up to six 
electrophoretic forms [3], and isoelectric focusing of 
pig-kidney enzymes has shown that fucosidases I and 
II from this organ are both heterogeneous [4]. In this 
paper we report the multiple forms that can be 
demonstrated by isoelectric focusing of human liver 
enzymes in polyacrylamide gel and in thin layers of 
Sephadex. 
2. Experimental 
2.1. Materials 
Ampholines (pH range 3.5- 10) were purchased 
from LKB Produkter AB Bromma, Sweden, and 
Sephadex G-50 Superfine for thin layer use from 
Pharmacia (G.B.) Ltd., London, W.5. Acrylamide and 
methylene N,ilr’-bis-acrylamide was from B.D.H. 
Chemicals Ltd., Poole, Dorset, and 4-methylumbelli- 
feryl o-Lfucoside from Koch-Light Laboratories, 
Colnbrook, Bucks. 
North-Holland Publishing Company - Amsterdam 
2.2. Enzyme preparations 
Homogenates of human liver (50% w/v) were 
prepared in distilled water, incorporating, when 
required, a final concentration of 0.1 mM phenyl- 
methylsulphonyl fluoride as protease inhibitor. The 
supernatants after centrifuging for 15 min at 9000 
rev/mm in an MSE 18’ refrigerated centrifuge were 
used as an initial source of the enzyme. The enzyme 
was also further purified by the affinity chromato- 
graphy procedure that has been reported previously 
[5], and fucosidases I and II were separated by gel 
filtration procedures as already published [ 1 ] . 
2.3. Acrylamide gel focusing 
Slabs of 6% polyacrylamide gel incorporating 
either 1% or 2% ampholines and 0.3% methylene 
NJ’-bis-acrylamide were polymerised in plastic trays 
(12 cm X 15 cm X 0.5 cm) as described by Vesterburg 
[6]. The slabs were cooled at 4°C and samples applied 
either directly onto the gel surface or on strips of 
filter paper. Carbon electrodes soaked in 1 M NaOH 
(cathode) or 1 M HZ SO4 (anode) were placed directly 
on the surface of the gel and focusing proceeded for 
1 S- 18 hr at 150 V. The location of focused isoenzyme 
was detected by applying to the surface a sheet of 
chromatography paper soaked in buffered 4-methylum- 
belliferyl cr-Lfucoside (1 mM in 100 mM phospate- 
citrate buffer pH 5.5). Liberated 4-methylumbelliferone 
could be seen under U.V. illumination and the 
fluorescence was intensified if necessary by treating 
the gel surface with 0.5 M glycine-NaOH buffer pH 
10.4. Proteins were stained with Coomassie brilliant 
blue R [6] and the pH gradient determined by 
cutting out samples of the gel and eluting in boiled 
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distilled water overnight before measuring the pH. were assayed for cu-Lfucosidase activity fluori- 
metrically [9]. 
2.4. Thin-layer focusing 
Thin layers of Sephadex G-50 superfine using 1% 
ampholine solutions were prepared as described by 
Badola [7] and allowed to dry partially to a matt 
surface before placing in a humidity chamber for 
isoelectric focusing. The sample was applied directly 
on the surface and electrical contact was made by 
cellulose acetate strips. The presence of focused o-L- 
fucosidase isoenzymes was detected by lightly spray- 
ing the surface with the buffered substrate mixture 
described above and viewing under U.V. light. The 
areas of activity could be scraped off, suspended in 
water and centrifuged free of Sephadex for further 
investigation. 
2.6. Neuraminidase treatment 
A 50% (w/v) homogenate of human liver was 
prepared in 5 mM phosphate-citrate buffer pH 4.0 
and centrifuged as before. The supernatant (100 ~1) 
was incubated with 25 units of Vibrio cholerae 
neuraminidase (Calbiochem B grade) for 5 hr at 37°C 
and the sample then focused without further treat- 
ment. Controls of untreated supernatant, and super- 
natant treated with boiled neuraminidase were run at 
the same time. An affinity purified sample of liver 
o-fucosidase was similarly examined. 
3. Results and discussion 
2.5. Column isoelectric focusing 
Human liver supernatant was focused using a Isoelectric focusing in columns (fig. 1) indicates 
sucrose gradient in an Ampholine type 8 100 column that human liver a-Lfucosidase is heterogeneous to an 
(LKB Instruments Ltd., London, SE. 20 UK) as extent not previously revealed by ion-exchange or gel- 
previously described [8] . The subsequent fractions filtration data. Four main components, with p1 values 
-6 
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Fig.1. Column isoelectric focusing of human-liver a-L-fucosidases assayed with 4-methylumbelliferyl cr-L-fucoside, (e-*) enzyme 
profile; (o-o) pH gradient. 
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between 5.0 and 6.5, can be clearly distinguished 
from the profile. A similar heterogeneity was shown 
by Wiederschain [4] and Alhadeff et al. [lo] . The 
presence of multiple forms is particularly evident after 
polyacrylamide gel focusing. The number of bands 
seen depended on the individual liver sample and on the 
length of time it was allowed to react with the 4- 
methylumbelliferyl substrate. All samples of liver had 
three strong bands of activity with pI values 6.3, 5.9 
and 5.6, and a fourth band pI 6.4 was frequently 
seen (tig.2a). Prolonged contact with the substrate 
revealed further bands, and up to nine components 
have been found in this way between the pI range 
4.9 to 6.4 (fig.2b). The results were unaffected by 
the ampholine concentration or by the initial position- 
ing of the sample. A comparison of two samples from 
the same liver, one of which had no added protease 
inhibitor, showed no visible differences. Samples of 
human placenta, kidney, serum and urine also show 
multiple forms similar to those in liver, but the 
relative proportions of each may vary from tissue to 
tissue. 
An attempt was made to estimate the quantitative 
contribution of each component to the overall activity 
of a liver sample that showed four major bands. These 
bands, with pI 6.4, 6.2, 5.9, and 5.6, had 18%, 25%, 
24% and 15% of the total activity, the remaining 
activity being largely accounted for by two other 
minor components. The results must be only regarded 
as semiquantitative, being obtained by removal of 
individual bands from a polyacrylamide gel and assay 
b J4-5 
pw 
Fig.2 Isoelectric focusing of human liver cu-L-fucosidases in 
acrylamide gel. (a) Individual livers, showing three and four 
major bands; (b) whole homogenate, developed to reveal 
weaker bands of activity, as described in the text. 
by the standard method [9]. No allowance was made 
for any differences in instability during the separation 
technique, but all forms appear to be of similar. 
stability in view of the way they survive through 
various separation processes. 
Three major bands with pI 6.2,5.9, and 5.6, which 
were obtained by electrofocusing of a liver sample 
in thin layer Sephadex, were scraped off, resuspended 
in water and the Sephadex centrifuged down. The 
resulting solutions were refocused in polyacrylamide 
and now each migrated as a single band that had 
retained its characteristic PI. Each of the forms thus 
appears to have a separate and stable identity, does 
not give rise to other forms by conformational 
changes, and their origin does not appear to be due 
to partial proteolysis during the extraction 
procedure. 
In agreement with earlier reports [3,10], 
neuraminidase treatment made no difference to the 
electrophoretic mobility of the major forms of the 
enzyme, but some of the minor bands of lower pZ 
value appeared to be transformed to new components 
when liver homogenate or purified enzyme was treated 
in this way. Samples of fucosidase I and II, separated 
by gel filtration, each gave a pattern identical to that 
obtained with the homogenate from which it was 
made. The individual components do not therefore 
segregate on a size basis. Our most highly purified 
sample of o-L-fucosidase, prepared by affinity 
chromatography and chromatographing as fucosidase 
I, was similarly heterogeneous. 
The nature of the multiple forms of a-L-fucosidase 
remains unexplained. If it is due simply to variations 
in sialic acid content then a good deal of the sub- 
stituent must be resistant to neuraminidase attack 
under the conditions used here. Some further struct- 
ural features may be important, and Turner et al. [3 ] 
have discussed the possibility of genetic polymorphism. 
Our observation that the number of major bands varies 
from one individual liver to another may support this. 
The evidence of isoelectric focusing of fucosidase I
and II leads us to ascribe these forms to different 
states of aggregation of the same group of 
isoenzymes. 
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